(Q47848068)

6 February 2018

title

Bone turnover during short-term therapy with methylprednisolone or budesonide in Crohn's disease (English)

1 reference

6 February 2018

1 reference

1 reference

6

Rutgeerts P

1 reference

6 February 2018

author name string

D'Haens G

1

1 reference

6 February 2018

Verstraete A

2

1 reference

6 February 2018

Cheyns K

3

1 reference

6 February 2018

Aerden I

4

1 reference

6 February 2018

Bouillon R

5

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 May 1998

1 reference

6 February 2018

Alimentary Pharmacology & Therapeutics

published in

1 reference

6 February 2018

volume

12

1 reference

6 February 2018

issue

5

1 reference

6 February 2018

page(s)

419-424

1 reference

6 February 2018

Osteoporosis in patients with inflammatory bowel disease

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00321.X

Bone disease in vitamin D-deficient patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00321.X

Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00321.X

A controlled study of bone mineral density in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00321.X

New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00321.X

10.1046/J.1365-2036.1998.00321.X

21 January 2018

Identifiers

DOI

1 reference

6 February 2018

PubMed ID

9663720

1 reference

6 February 2018